Tetraphase Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2006-01-01
- Employees
- 67
- Market Cap
- -
- Website
- http://tphase.com
Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-11-21
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01989949
- Locations
- 🇺🇸
Center for Anti-infective Research and Development; Hartford Hospital, Hartford, Connecticut, United States
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
- First Posted Date
- 2013-11-08
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Target Recruit Count
- 908
- Registration Number
- NCT01978938
- Locations
- 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Columbus Regional Research Institute, Columbus, Ohio, United States
🇨🇿Thomayer Hospital, Department of Urology, Prague, Czechia
A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2021-12-27
- Lead Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT01941446
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Target Recruit Count
- 541
- Registration Number
- NCT01844856
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-12-23
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Target Recruit Count
- 143
- Registration Number
- NCT01265784
- Locations
- 🇧🇬
MHAT "Russe" AD, Russe, Russe, Bulgaria
🇺🇸Barnes Jewish Hospital, Saint Louis, Missouri, United States
🇺🇸Long Beach VA Medical Center, Long Beach, California, United States
© Copyright 2024. All Rights Reserved by MedPath